Cita APA

Coutré, S. E., Barrientos, J. C., Brown, J. R., de Vos, S., Furman, R. R., Keating, M. J., . . . Zelenetz, A. D. (2015). Management of adverse events associated with idelalisib treatment: Expert panel opinion. Leuk Lymphoma.

Chicago Style Citation

Coutré, Steven E., et al. "Management of Adverse Events Associated With Idelalisib Treatment: Expert Panel Opinion." Leuk Lymphoma 2015.

Cita MLA

Coutré, Steven E., et al. "Management of Adverse Events Associated With Idelalisib Treatment: Expert Panel Opinion." Leuk Lymphoma 2015.